Fri, Jul 11, 2014, 7:17 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Kedem Pharmaceuticals, Inc. Message Board

  • tradr.jedi tradr.jedi Feb 7, 2012 1:52 PM Flag

    Kedem Sublingual Drug Delivery System Introduced at World Money Show

    Great exposure for the company:

    PHOENIX, AZ--(Marketwire -02/07/12)- Kedem Pharmaceuticals Inc. (OTC.BB: KDMP.OB - News), a specialty pharmaceutical company with focus on sublingual drug delivery is pleased to participate February 9 -12 at the World Money Show in Orlando, Fl., Booth #609, The company CEO Dr. Hasssan Salari will be on hand to discuss with the attendees the company's progress on X-Excite, the Company's lead therapeutic drug for erectile dysfunction. The Company's second lead therapeutic drug KDM-1102, which is a new sublingual formulation of Propanolol for cardiovascular diseases. The newest drug initiated into development of Gleevec®. Gleevec® is an important anti-cancer drug for the treatment of several blood related cancers in children and adults.

    Dr. Hassan Salari, Ph.D, C.E.O. expressed, "We were pleased to Welcome the Investors at the World Money Show forum and are excited to have a platform for review by the investment community. We welcome the opportunity to inform our shareholders in more detail about our goals to commercialize our sublingual drug delivery system.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.00010.0000(0.00%)Jul 8 11:10 AMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.